Click for best price
Novel Drug Delivery Systems for Cancer Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems for Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems for Cancer Therapy. This report contains market size and forecasts of Novel Drug Delivery Systems for Cancer Therapy in global, including the following market information:
Global Novel Drug Delivery Systems for Cancer Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Novel Drug Delivery Systems for Cancer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Embolization Particles ? Drug Eluting Beads Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Novel Drug Delivery Systems for Cancer Therapy include Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc and Eckert & Ziegler BEBIG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Novel Drug Delivery Systems for Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Drug Delivery Systems for Cancer Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, by Type, 2022 (%)
Embolization Particles ? Drug Eluting Beads
Polyvinyl Alcohol Particles
Microspheres
Gelatin-Based Embolization Devices
Selective Internal Radiation Therapy
Holmium-Based Microspheres
Liquid Embolics ? Onyx
Other
Global Novel Drug Delivery Systems for Cancer Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Novel Drug Delivery Systems for Cancer Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Drug Delivery Systems for Cancer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Novel Drug Delivery Systems for Cancer Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Medical Isotope Corporation
Bind Therapeutics
Boston Scientific Corporation
BTG plc
CeloNova BioSciences, Inc.
Cook Medical, Inc.
Cospheric LLC
Covidien, plc
Eckert & Ziegler BEBIG
EmboMedics, Inc.
Kobo Products, Inc.
Merit Medical Systems, Inc.
Mo-Sci Corporation
Nanobiotix
Polysciences, Inc.
Sirtex Medical, Inc.
Terumo Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Novel Drug Delivery Systems for Cancer Therapy, market overview.
Chapter 2: Global Novel Drug Delivery Systems for Cancer Therapy market size in revenue.
Chapter 3: Detailed analysis of Novel Drug Delivery Systems for Cancer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Novel Drug Delivery Systems for Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Novel Drug Delivery Systems for Cancer Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Novel Drug Delivery Systems for Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Drug Delivery Systems for Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Drug Delivery Systems for Cancer Therapy Overall Market Size
2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size: 2022 VS 2032
2.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Novel Drug Delivery Systems for Cancer Therapy Players in Global Market
3.2 Top Global Novel Drug Delivery Systems for Cancer Therapy Companies Ranked by Revenue
3.3 Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Novel Drug Delivery Systems for Cancer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Novel Drug Delivery Systems for Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Novel Drug Delivery Systems for Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Novel Drug Delivery Systems for Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems for Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Market Size Markets, 2022 & 2032
4.1.2 Embolization Particles ? Drug Eluting Beads
4.1.3 Polyvinyl Alcohol Particles
4.1.4 Microspheres
4.1.5 Gelatin-Based Embolization Devices
4.1.6 Selective Internal Radiation Therapy
4.1.7 Holmium-Based Microspheres
4.1.8 Liquid Embolics ? Onyx
4.1.9 Other
4.2 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2023
4.2.2 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2024-2032
4.2.3 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2023
5.2.2 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2024-2032
5.2.3 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Market Size, 2022 & 2032
6.2 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2023
6.2.2 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2024-2032
6.2.3 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2032
6.3.2 US Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.3.3 Canada Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.3.4 Mexico Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2032
6.4.2 Germany Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4.3 France Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4.4 U.K. Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4.5 Italy Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4.6 Russia Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.4.8 Benelux Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2032
6.5.2 China Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.5.3 Japan Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.5.4 South Korea Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.5.6 India Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2032
6.6.2 Brazil Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.6.3 Argentina Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2032
6.7.2 Turkey Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.7.3 Israel Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
6.7.5 UAE Novel Drug Delivery Systems for Cancer Therapy Market Size, 2018-2032
7 Novel Drug Delivery Systems for Cancer Therapy Companies Profiles
7.1 Advanced Medical Isotope Corporation
7.1.1 Advanced Medical Isotope Corporation Company Summary
7.1.2 Advanced Medical Isotope Corporation Business Overview
7.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.1.4 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.1.5 Advanced Medical Isotope Corporation Key News & Latest Developments
7.2 Bind Therapeutics
7.2.1 Bind Therapeutics Company Summary
7.2.2 Bind Therapeutics Business Overview
7.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.2.4 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.2.5 Bind Therapeutics Key News & Latest Developments
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Company Summary
7.3.2 Boston Scientific Corporation Business Overview
7.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.3.4 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.3.5 Boston Scientific Corporation Key News & Latest Developments
7.4 BTG plc
7.4.1 BTG plc Company Summary
7.4.2 BTG plc Business Overview
7.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.4.4 BTG plc Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.4.5 BTG plc Key News & Latest Developments
7.5 CeloNova BioSciences, Inc.
7.5.1 CeloNova BioSciences, Inc. Company Summary
7.5.2 CeloNova BioSciences, Inc. Business Overview
7.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.5.4 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.5.5 CeloNova BioSciences, Inc. Key News & Latest Developments
7.6 Cook Medical, Inc.
7.6.1 Cook Medical, Inc. Company Summary
7.6.2 Cook Medical, Inc. Business Overview
7.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.6.4 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.6.5 Cook Medical, Inc. Key News & Latest Developments
7.7 Cospheric LLC
7.7.1 Cospheric LLC Company Summary
7.7.2 Cospheric LLC Business Overview
7.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.7.4 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.7.5 Cospheric LLC Key News & Latest Developments
7.8 Covidien, plc
7.8.1 Covidien, plc Company Summary
7.8.2 Covidien, plc Business Overview
7.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.8.4 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.8.5 Covidien, plc Key News & Latest Developments
7.9 Eckert & Ziegler BEBIG
7.9.1 Eckert & Ziegler BEBIG Company Summary
7.9.2 Eckert & Ziegler BEBIG Business Overview
7.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.9.4 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.9.5 Eckert & Ziegler BEBIG Key News & Latest Developments
7.10 EmboMedics, Inc.
7.10.1 EmboMedics, Inc. Company Summary
7.10.2 EmboMedics, Inc. Business Overview
7.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.10.4 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.10.5 EmboMedics, Inc. Key News & Latest Developments
7.11 Kobo Products, Inc.
7.11.1 Kobo Products, Inc. Company Summary
7.11.2 Kobo Products, Inc. Business Overview
7.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.11.4 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.11.5 Kobo Products, Inc. Key News & Latest Developments
7.12 Merit Medical Systems, Inc.
7.12.1 Merit Medical Systems, Inc. Company Summary
7.12.2 Merit Medical Systems, Inc. Business Overview
7.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.12.4 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.12.5 Merit Medical Systems, Inc. Key News & Latest Developments
7.13 Mo-Sci Corporation
7.13.1 Mo-Sci Corporation Company Summary
7.13.2 Mo-Sci Corporation Business Overview
7.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.13.4 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.13.5 Mo-Sci Corporation Key News & Latest Developments
7.14 Nanobiotix
7.14.1 Nanobiotix Company Summary
7.14.2 Nanobiotix Business Overview
7.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.14.4 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.14.5 Nanobiotix Key News & Latest Developments
7.15 Polysciences, Inc.
7.15.1 Polysciences, Inc. Company Summary
7.15.2 Polysciences, Inc. Business Overview
7.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.15.4 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.15.5 Polysciences, Inc. Key News & Latest Developments
7.16 Sirtex Medical, Inc.
7.16.1 Sirtex Medical, Inc. Company Summary
7.16.2 Sirtex Medical, Inc. Business Overview
7.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.16.4 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.16.5 Sirtex Medical, Inc. Key News & Latest Developments
7.17 Terumo Corporation
7.17.1 Terumo Corporation Company Summary
7.17.2 Terumo Corporation Business Overview
7.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
7.17.4 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global Market (2018-2023)
7.17.5 Terumo Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Novel Drug Delivery Systems for Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Novel Drug Delivery Systems for Cancer Therapy Market Drivers in Global Market
Table 3. Novel Drug Delivery Systems for Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Novel Drug Delivery Systems for Cancer Therapy in Global Market
Table 5. Top Novel Drug Delivery Systems for Cancer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Novel Drug Delivery Systems for Cancer Therapy Product Type
Table 9. List of Global Tier 1 Novel Drug Delivery Systems for Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems for Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Advanced Medical Isotope Corporation Company Summary
Table 31. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 32. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Advanced Medical Isotope Corporation Key News & Latest Developments
Table 34. Bind Therapeutics Company Summary
Table 35. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 36. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bind Therapeutics Key News & Latest Developments
Table 38. Boston Scientific Corporation Company Summary
Table 39. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 40. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Boston Scientific Corporation Key News & Latest Developments
Table 42. BTG plc Company Summary
Table 43. BTG plc Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 44. BTG plc Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. BTG plc Key News & Latest Developments
Table 46. CeloNova BioSciences, Inc. Company Summary
Table 47. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 48. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. CeloNova BioSciences, Inc. Key News & Latest Developments
Table 50. Cook Medical, Inc. Company Summary
Table 51. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 52. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Cook Medical, Inc. Key News & Latest Developments
Table 54. Cospheric LLC Company Summary
Table 55. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 56. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Cospheric LLC Key News & Latest Developments
Table 58. Covidien, plc Company Summary
Table 59. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 60. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Covidien, plc Key News & Latest Developments
Table 62. Eckert & Ziegler BEBIG Company Summary
Table 63. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 64. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Eckert & Ziegler BEBIG Key News & Latest Developments
Table 66. EmboMedics, Inc. Company Summary
Table 67. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 68. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. EmboMedics, Inc. Key News & Latest Developments
Table 70. Kobo Products, Inc. Company Summary
Table 71. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 72. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Kobo Products, Inc. Key News & Latest Developments
Table 74. Merit Medical Systems, Inc. Company Summary
Table 75. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 76. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Merit Medical Systems, Inc. Key News & Latest Developments
Table 78. Mo-Sci Corporation Company Summary
Table 79. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 80. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Mo-Sci Corporation Key News & Latest Developments
Table 82. Nanobiotix Company Summary
Table 83. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 84. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Nanobiotix Key News & Latest Developments
Table 86. Polysciences, Inc. Company Summary
Table 87. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 88. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Polysciences, Inc. Key News & Latest Developments
Table 90. Sirtex Medical, Inc. Company Summary
Table 91. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 92. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Sirtex Medical, Inc. Key News & Latest Developments
Table 94. Terumo Corporation Company Summary
Table 95. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product Offerings
Table 96. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Terumo Corporation Key News & Latest Developments
List of Figures
Figure 1. Novel Drug Delivery Systems for Cancer Therapy Segment by Type in 2022
Figure 2. Novel Drug Delivery Systems for Cancer Therapy Segment by Application in 2022
Figure 3. Global Novel Drug Delivery Systems for Cancer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Novel Drug Delivery Systems for Cancer Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2022
Figure 8. By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 16. US Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 28. China Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Novel Drug Delivery Systems for Cancer Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BTG plc Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
